India's Sun Pharma gets tentative ok for Gleevec generic
MUMBAI, Nov 17 (Reuters) - India's Sun Pharma (SUN.BO: Quote, Profile, Research) said on Tuesday the U.S. Food and Drug Administration has given tentative approval for its generic version of Novartis' (NOVN.VX: Quote, Profile, Research) Gleevec, used to treat leukemia. (Reporting by Jeanette Rodrigues; Editing by Anshuman Daga)
© Thomson Reuters 2010 All rights reserved
Economy seen growing at 7.2 pct in FY10 - govt
The forecast reinforces the possibility that the government may start to unwind its fiscal stimulus in the budget. Full Article
AIDING GREECE
Eurozone agree in principle to aid Greece - source
Euro zone countries decide to help debt-stricken Greece. Full Article | Video



India
US
UK






